Drug Trial Radar · NCT06990867
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
740
Planned (sponsor's estimate)
Start
May 15, 2025
Primary completion
Oct 31, 2029
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Corxel PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin Scale score when compared with placebo following AIS. 2. Risk of symptomatic intracranial hemorrhage of JX10 in participants with AIS. During Part 1, participants will be randomized to JX 10 (1mg/kg, 3 mg/kg) or placebo. During Part 2, participants will receive JX10 (optimal dose chosen from Part 1) or placebo.
Conditions
- Acute Ischemic Stroke
Interventions
JX10Drug
JX10 is a thrombolytic agent.
PlaceboDrug
Placebo is being used as the comparator.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy: Proportion of participants with no or minimal symptoms (mRS score 0-1) at 90 daysTime frame: 90 days
- Safety: Incidence of symptomatic intracranial hemorrhage within 36 hours post-randomizationTime frame: Within 36 hours post-randomization
Locations
104 sites in 21 countries. Site status is shown where the registry gives one.
Corxel Investigational Site
Long Beach, California · Recruiting
Corxel Investigational Site
Los Angeles, California · Recruiting
Corxel Investigational Site
Sacramento, California · Recruiting
Corxel Investigational Site
Colorado Springs, Colorado · Recruiting
Corxel Investigational Site
Washington D.C., District of Columbia · Recruiting
Corxel Investigational Site
Delray Beach, Florida · Recruiting
Corxel Investigational Site
Chicago, Illinois · Recruiting
Corxel Investigational Site
Wichita, Kansas · Recruiting
Corxel Investigational Site
Baltimore, Maryland · Recruiting
Corxel Investigational Site
Kalamazoo, Michigan · Recruiting
Corxel Investigational Site
Traverse City, Michigan · Recruiting
Corxel Investigational Site
St Louis, Missouri · Recruiting
Corxel Investigational Site
Great Neck, New York · Recruiting
Corxel Investigational Site
New York, New York · Recruiting
Corxel Investigational Site
Columbus, Ohio · Recruiting
Corxel Investigational Site
Toledo, Ohio · Recruiting
Corxel Investigational Site
Tulsa, Oklahoma · Recruiting
Corxel Investigational Site
Chattanooga, Tennessee · Recruiting
Corxel Investigational Site
Dallas, Texas · Recruiting
Corxel Investigational Site
Houston, Texas · Recruiting
Corxel Investigational Site
Ghent, Belgium · Recruiting
Corxel Investigational Site
Hasselt, Belgium · Recruiting
Corxel Investigational Site
Blagoevgrad, Bulgaria · Recruiting
Corxel Investigational Site
Burgas, Bulgaria · Recruiting
Corxel Investigational Site
Pleven, Bulgaria · Recruiting
Corxel Investigational Site
Plovdiv, Bulgaria · Recruiting
Corxel Investigational Site
Sofia, Bulgaria · Recruiting
Corxel Investigational Site
Edmonton, Canada · Recruiting
Corxel Investigational Site
Kingston, Canada · Recruiting
Corxel Investigational Site
Winnipeg, Canada · Recruiting
Corxel Investigational Site
Baotou, China · Recruiting
Corxel Investigational Site
Beijing, China · Recruiting
Corxel Investigational Site
Beijing, China · Recruiting
Corxel Investigational Site
Changchun, China · Recruiting
Corxel Investigational Site
Guangzhou, China · Recruiting
Corxel Investigational Site,
Harbin, China · Recruiting
Corxel Investigational Site
Harbin, China · Recruiting
Corxel Investigational Site
Kaili, China · Recruiting
Corxel Investigational Site
Linfen, China · Recruiting
Corxel Investigational Site
Nanyang, China · Recruiting
Showing 40 of 104 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.